Use of oxymethylene aryl GPR119 agonists and DPP IV inhibitors for the treatment of diabetic diseases, including Type II diabetes and other diseases associated with poor glycemic control are provided. A band gap reference power supply circuit 6 supplies an internal reference voltage to a characteristic adjusting circuit 4 and an internal reference voltage VINT to a multiplier circuit 5. The feeder feeds the bio-waste into the chamber.